A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 162-167

  Ren, Jie ^a   Peng, Zhilan ^a   Yang, Kaixuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Borderline ovarian tumors; Recurrence; Risk factors

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARY TUMOR; PERITONEUM METASTASIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 47249135990     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.03.019     Document Type: Article

References (18)

1. Taylor H.C. Malignant and semimalignant tumors of the ovary. Surg Gynecol Obstet 48 (1929) 204-230
2. Cusidó M., Balagueró L., Hernandez G., Falcón O., Rodríguez-Escudero F.J., Vargas J.A., et al. Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol 104 (2007) 617-622
3. Boran N., Cil A.P., and Tulunay G. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97 (2005) 845-851
4. Maneo A., Vignali M., Chiari S., Colombo A., Mangioni C., and Landoni F. Are borderline tumors of the ovary safely treated by laparoscopy?. Gynecol Oncol 94 (2004) 387-392
5. Scully R.E. International histological classification and staging of tumors (1999), World Health Organization
6. International Federation of Gynecology and Obstetrics: changes in definitions of clinical staging for carcinoma of the cervix and the ovary. Am J Obstet Gynecol 156 (1987) 263-264
7. Engelen M.J., de Bruijn H.W., Hollema H., et al. Serum CA125, carcinoembryonic antigen, and CA19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 78 (2000) 16-20
8. Trimble C.L., Kosary C., and Trimble E. Long-term survival and patterns of care in women with ovarian tumours of low malignant potential. Gynecol Oncol 86 (2002) 34-37
9. Suh-Burgmann E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103 (2006) 841-847
10. Camatte S., Morice P., Atallah D., Pautier P., Lhommé C., Haie-Meder C., Duvillard P., et al. Lymph node disorders and prognostic value of nodal involvement in patient treated for a borderline ovarian tumor:an analysis of a series of 42 lymphadenectomies. J Am Coll Surgeons 195 (2002) 332-338
11. Zanetta G., Rota S., Chiari S., Bonazzi C., Bratina G., and Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: A prospective study. J Clin Oncol 19 (2001) 2658-2664
12. Sevcik L., Klat J., Koliba P., and Curik R. Radical surgical therapy and role of adjuvant chemotherapy in ovarian tumors of borderline malignancy. Cesk Gynek 69 (2004) 488-492
13. Hogg R., Scurry J., Kim S.N., Friedlander M., and Hacker N. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma. Gynecol Oncol 106 (2007) 44-51
14. Morris R.T., Gershenson D.M., Silva E.G., Follen M., Morris M., and Wharton J.T. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 95 (2000) 541-547
15. Buttin B.M., Herzog T.J., Powell M.A., Rader J.S., and Mutch D.G. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obste Gynecol 99 (2002) 11-17
16. Smith Schdev A.E., Schdev P.S., and Kurman R.J. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathological analysis of 135 cases. Am J Surg Pathol 27 (2003) 725-736
17. Silva E.G., Gershenson D.M., Malpica A., and Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 30 (2006) 1367-1371
18. Longacre T.A., McKenney J.K., Tazelaar H.D., Kempson R.L., and Hendrickson M.R. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> = 5-Year) follow-up. Am J Surg Pathol. 29 (2005) 707-723